Prognosis in patients with MDS or AML and bone marrow blasts between 10% and 30% is not associated with blast counts but depends on cytogenetic and molecular genetic characteristics.
Saved in:
| Title: | Prognosis in patients with MDS or AML and bone marrow blasts between 10% and 30% is not associated with blast counts but depends on cytogenetic and molecular genetic characteristics. |
|---|---|
| Authors: | Bacher, U.1, Kern, W.2, Alpermann, T.2, Schnittger, S.2, Kohlmann, A.2, Klein, H.-U.3, Dugas, M.3, Haferlach, C.2, Haferlach, T.2 torsten.haferlach@mll.com |
| Source: | Leukemia (08876924). Aug2011, Vol. 25 Issue 8, p1361-1364. 4p. 1 Chart, 1 Graph. |
| Database: | Academic Search Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 64003162 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Prognosis in patients with MDS or AML and bone marrow blasts between 10% and 30% is not associated with blast counts but depends on cytogenetic and molecular genetic characteristics. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Bacher%2C+U%2E%22">Bacher, U.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Kern%2C+W%2E%22">Kern, W.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Alpermann%2C+T%2E%22">Alpermann, T.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Schnittger%2C+S%2E%22">Schnittger, S.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Kohlmann%2C+A%2E%22">Kohlmann, A.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Klein%2C+H%2E-U%2E%22">Klein, H.-U.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Dugas%2C+M%2E%22">Dugas, M.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Haferlach%2C+C%2E%22">Haferlach, C.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Haferlach%2C+T%2E%22">Haferlach, T.</searchLink><relatesTo>2</relatesTo><i> torsten.haferlach@mll.com</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Leukemia+%2808876924%29%22">Leukemia (08876924)</searchLink>. Aug2011, Vol. 25 Issue 8, p1361-1364. 4p. 1 Chart, 1 Graph. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=64003162 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/leu.2011.80 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 4 StartPage: 1361 Titles: – TitleFull: Prognosis in patients with MDS or AML and bone marrow blasts between 10% and 30% is not associated with blast counts but depends on cytogenetic and molecular genetic characteristics. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bacher, U. – PersonEntity: Name: NameFull: Kern, W. – PersonEntity: Name: NameFull: Alpermann, T. – PersonEntity: Name: NameFull: Schnittger, S. – PersonEntity: Name: NameFull: Kohlmann, A. – PersonEntity: Name: NameFull: Klein, H.-U. – PersonEntity: Name: NameFull: Dugas, M. – PersonEntity: Name: NameFull: Haferlach, C. – PersonEntity: Name: NameFull: Haferlach, T. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: Aug2011 Type: published Y: 2011 Identifiers: – Type: issn-print Value: 08876924 Numbering: – Type: volume Value: 25 – Type: issue Value: 8 Titles: – TitleFull: Leukemia (08876924) Type: main |
| ResultId | 1 |
